Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regeneron Pharmaceuticals | REGN | Sep 3, 2024 | 1 168.81 | -1.34 |
REGENXBIO | RGNX | Sep 3, 2024 | 11.34 | -7.20 |
Regional Health Properties | RHE | Sep 3, 2024 | 1.86 | +0.27 |
Regional Health Properties A Pref | RHE-A | Sep 3, 2024 | 0.46 | 0.00 |
Regional Management | RM | Sep 3, 2024 | 32.56 | -2.89 |
Regions Financial | RF | Sep 3, 2024 | 23.00 | -1.79 |
Regions Financial B Pref | RF-B | Sep 3, 2024 | 24.94 | -1.66 |
Regions Financial C Pref | RF-C | Sep 3, 2024 | 23.82 | +0.17 |
Regions Financial E Pref | RF-E | Sep 3, 2024 | 18.29 | -1.30 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Sep 3, 2024 | 25.32 | 0.00 |
Regis | RGS | Sep 3, 2024 | 19.90 | -5.24 |
Regulus Therapeutics | RGLS | Sep 3, 2024 | 1.57 | -6.55 |
Reinsurance Group of America | RGA | Sep 3, 2024 | 218.10 | -1.20 |
REIT Index ETF Vanguard | VNQ | Sep 3, 2024 | 95.08 | -0.05 |
Rekor Systems | REKR | Sep 3, 2024 | 1.18 | -5.60 |
Relay Therapeutics | RLAY | Sep 3, 2024 | 6.47 | -4.71 |
Reliance | RS | Sep 3, 2024 | 272.79 | -4.84 |
Reliance Global | RELI | Sep 3, 2024 | 2.69 | -3.93 |
Relmada Therapeutics | RLMD | Sep 3, 2024 | 2.74 | -2.14 |
RELX ADR | RELX | Sep 3, 2024 | 46.15 | -1.09 |
Remitly Global | RELY | Sep 3, 2024 | 13.44 | -1.54 |
Renaissance Ipo ETF | IPO | Sep 3, 2024 | 40.56 | -2.90 |
RenaissanceRe | RNR | Sep 3, 2024 | 256.94 | +0.84 |
RenaissanceRe G Pref | RNR-G | Sep 3, 2024 | 18.28 | +0.11 |
RenaissanceRe Holding F Pref | RNR-F | Sep 3, 2024 | 24.55 | -0.20 |
Renalytix ADR | RNLX | Sep 3, 2024 | 0.28 | -10.83 |
Renasant | RNST | Sep 3, 2024 | 34.74 | -0.74 |
Reneo Pharmaceuticals | RPHM | Sep 3, 2024 | 1.43 | -3.38 |
ReNew Energy Global A Shares | RNW | Sep 3, 2024 | 5.69 | +1.25 |
Renn Fund | RCG | Sep 3, 2024 | 1.86 | -1.06 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.